Scientific Sessions

Emerging and re-emerging pathogens pose significant threats to global health, requiring vigilant monitoring and rapid response. This session integrates Infectious Diseases, Epidemiology & Public Health, and Disease Prevention & Control principles to explore factors driving the appearance and reappearance of infectious agents. Participants will examine zoonotic transmission, environmental influences, and the impact of human behavior on pathogen spread. Discussions will include strategies for early detection, containment, and community-level intervention, emphasizing lessons from recent global outbreaks. The session also highlights the role of innovative surveillance systems and cross-border collaborations in reducing the burden of emerging infectious diseases.

The session further examines the challenges in managing newly identified pathogens with limited clinical knowledge and treatment options. By incorporating Vaccines and Immunization strategies and exploring antimicrobial approaches, participants will gain insights into proactive interventions to mitigate outbreaks. Attendees will learn evidence-based frameworks to implement prevention and control measures, ensuring timely action and reducing the risk of widespread transmission.

Key Highlights

• Identification and characterization of emerging pathogens
• Outbreak prediction and risk assessment strategies
• Integrating vaccines and antimicrobial approaches
• Community-level prevention and control measures
• Cross-disciplinary collaboration and rapid response

Why This Session Is Important?

Emerging infectious diseases can escalate rapidly if not properly managed. This session equips healthcare professionals, researchers, and policymakers with practical tools to anticipate, prevent, and respond to new infectious threats.

Effective surveillance and epidemiologic analysis are central to controlling the spread of infectious agents. This session emphasizes the application of Infectious Diseases, Epidemiology & Public Health, and Disease Prevention & Control in establishing robust monitoring systems. Participants will explore advanced epidemiologic tools, real-time data analytics, and outbreak detection methodologies. The discussion will include the integration of global and local reporting networks to provide timely, actionable insights for public health decision-making.

Participants will also examine the contribution of Vaccines and Immunization programs in reducing disease incidence, alongside methods for monitoring vaccine efficacy and coverage. Case studies will highlight successful strategies for mitigating disease outbreaks through proactive surveillance and data-driven interventions. Attendees will gain knowledge to design and implement epidemiological frameworks that optimize health outcomes and guide evidence-based policymaking.

Key Highlights

• Advanced infectious disease surveillance methodologies
• Epidemiologic modeling and outbreak forecasting
• Data-driven strategies for public health interventions
• Monitoring vaccine impact and coverage
• Integration of global and local health networks

Why This Session Is Important?

Robust surveillance is essential for early outbreak detection and response. This session provides actionable insights for epidemiologists, clinicians, and public health professionals to strengthen disease monitoring systems and improve population health outcomes.

The COVID-19 pandemic has reshaped the global approach to Infectious Diseases, highlighting the critical role of Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. This session explores SARS-CoV-2 alongside other coronaviruses, examining viral evolution, transmission patterns, and the effectiveness of containment measures. Participants will analyze case studies from diverse regions to understand outbreak management, policy interventions, and the integration of real-time data for epidemic forecasting.

Further discussion will cover the challenges of vaccine deployment, public health communication, and combating misinformation. Participants will explore Antimicrobial Resistance (AMR) implications in the context of secondary infections during viral outbreaks and strategies to maintain effective infection control. Attendees will gain insights into coordinated public health responses, evidence-based vaccination programs, and proactive measures to mitigate future coronavirus-related threats.

Key Highlights

• Coronavirus epidemiology and outbreak trends
• Vaccine implementation and booster strategies
• Antimicrobial resistance considerations during viral outbreaks
• Public health communication and disease control measures
• Policy frameworks for pandemic preparedness

Why This Session Is Important?

Understanding coronaviruses is essential to prepare for current and future pandemics. This session equips healthcare professionals, researchers, and policymakers with tools to respond effectively and safeguard public health.

HIV/AIDS continues to be a significant global health challenge, necessitating advanced strategies in Infectious Diseases, Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. This session covers the latest in antiretroviral therapy, breakthrough research in vaccine development, and innovative prevention programs. Participants will explore the global burden of HIV, emerging trends in high-risk populations, and evidence-based approaches to reduce transmission.

The session also highlights the role of Antimicrobial Resistance (AMR) in co-infections among HIV patients, addressing treatment challenges and public health implications. By combining research insights with practical public health interventions, attendees will learn to implement holistic strategies that optimize patient outcomes, prevent new infections, and strengthen community health programs.

Key Highlights

• Advances in antiretroviral therapy and clinical management
• HIV vaccine research and preventive strategies
• Integration of epidemiology and public health approaches
• Addressing antimicrobial resistance in co-infections
• Community-based disease prevention and care programs

Why This Session Is Important?

Staying abreast of HIV/AIDS research is critical for reducing transmission and improving patient outcomes. This session equips participants with strategies to enhance treatment, prevention, and public health impact globally.

Sexually transmitted infections, including HIV, remain a critical component of Infectious Diseases, requiring focused Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization strategies. Participants will examine current trends, high-risk populations, and innovative interventions to reduce transmission. The session emphasizes evidence-based approaches to diagnostics, treatment, and preventive education, integrating lessons from community outreach and public health campaigns.

Antimicrobial Resistance (AMR) poses additional challenges in the treatment of bacterial STDs, highlighting the need for vigilant monitoring and responsible prescribing. Attendees will explore best practices for combining clinical care with public health strategies to reduce disease burden, implement preventive measures, and support health equity in diverse populations.

Key Highlights

• Epidemiology and clinical management of STDs
• Vaccine development for preventable infections
• Public health and educational interventions
• Addressing antimicrobial resistance in STD treatment
• Community outreach and prevention strategies

Why This Session Is Important?

Effective management of STDs is essential to prevent long-term health complications and transmission. This session equips healthcare providers and public health professionals with tools to implement prevention, treatment, and education initiatives.

Ebola, Zika, and other viral infections remain high-priority threats in Infectious Diseases, demanding attention to Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. This session examines the virology, transmission mechanisms, and clinical manifestations of emerging viral pathogens. Participants will explore rapid diagnostic tools, outbreak surveillance techniques, and strategies to strengthen community-level response systems. Real-world case studies illustrate successful containment and mitigation efforts, emphasizing lessons for global preparedness.

The session also highlights challenges posed by Antimicrobial Resistance (AMR) in co-infections during viral outbreaks and explores the integration of vaccination programs to reduce disease burden. Attendees will gain insights into designing evidence-based interventions, improving patient outcomes, and coordinating multi-level public health strategies that enhance preparedness and resilience against viral epidemics.

Key Highlights

• Viral pathogen epidemiology and clinical management
• Rapid diagnostics and outbreak surveillance
• Vaccine deployment and immunization strategies
• Addressing antimicrobial resistance in co-infections
• Public health response frameworks and community preparedness

Why This Session Is Important?

Emerging viral infections pose global health risks. This session equips healthcare professionals and policymakers with the knowledge to anticipate outbreaks, implement effective interventions, and protect vulnerable populations.

Effective prevention and control of infectious agents are central to reducing morbidity and mortality worldwide. This session integrates Infectious Diseases, Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization approaches to explore strategies for minimizing the spread of pathogens. Participants will examine hygiene, sterilization, and vaccination protocols, alongside outbreak containment measures in healthcare and community settings. Case studies highlight successes in reducing disease transmission through evidence-based interventions.

The session further emphasizes Antimicrobial Resistance (AMR) management, including rational prescribing practices, stewardship programs, and global initiatives to curb resistant pathogens. Attendees will gain practical knowledge for implementing integrated prevention strategies that combine clinical care, public health initiatives, and community engagement to improve overall population health.

Key Highlights

• Infection control and hygiene protocols
• Vaccination programs and immunization strategies
• Disease prevention campaigns and community engagement
• Antimicrobial resistance management
• Evidence-based outbreak control and containment

Why This Session Is Important?

Preventing infectious diseases is more effective than treatment alone. This session equips professionals with actionable strategies to reduce transmission, improve patient outcomes, and safeguard public health.

Children are particularly vulnerable to infectious agents, making specialized care essential in Infectious Diseases, Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. This session explores the epidemiology, clinical management, and preventive measures for pediatric infections, from routine illnesses to rare viral and bacterial diseases. Participants will examine vaccination strategies, antibiotic stewardship, and early diagnostic tools to improve pediatric outcomes.

The session also addresses Antimicrobial Resistance (AMR) challenges in pediatric populations and strategies for responsible prescribing. By integrating public health principles with clinical care, attendees will learn to implement comprehensive infection control, improve vaccination coverage, and support community-level interventions for healthier childhood populations.

Key Highlights

• Pediatric infection diagnosis and treatment
• Vaccination strategies and immunization compliance
• Antibiotic stewardship and resistance management
• Community and school-based disease prevention
• Early detection and outbreak containment

Why This Session Is Important?

Pediatric infectious disease management protects children’s health and development. This session equips healthcare providers with evidence-based strategies for prevention, treatment, and long-term wellbeing of pediatric populations.

HPV and other oncogenic viruses present significant challenges in Infectious Diseases, requiring focused attention on Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. This session examines the global burden of HPV, modes of transmission, and risk factors contributing to cervical and other cancers. Participants will explore vaccination strategies, screening programs, and early intervention protocols that reduce disease incidence and improve patient outcomes.

The session also considers Antimicrobial Resistance (AMR) in the context of co-infections and secondary bacterial complications, highlighting evidence-based approaches to prevention and treatment. By integrating public health policies with clinical care, attendees will gain insights into comprehensive strategies for reducing HPV-related disease and improving population health.

Key Highlights

• HPV epidemiology and oncogenic virus surveillance
• Vaccine implementation and immunization strategies
• Early detection and screening programs
• Antimicrobial resistance considerations
• Public health outreach and education

Why This Session Is Important?

Reducing HPV and oncogenic viral infections prevents cancer and improves public health outcomes. This session equips healthcare professionals with actionable strategies for prevention, screening, and vaccination programs.

Streptococcal and staphylococcal infections continue to cause significant morbidity and mortality in Infectious Diseases, emphasizing Epidemiology & Public Health, Disease Prevention & Control, and the role of Vaccines and Immunization where applicable. Participants will explore transmission dynamics, risk populations, and the latest evidence-based clinical interventions to reduce infection rates.

The session also addresses Antimicrobial Resistance (AMR) challenges and strategies to optimize antibiotic use, including stewardship programs and treatment guidelines. Attendees will gain practical insights for integrating clinical care with public health initiatives to minimize outbreaks, improve patient outcomes, and implement effective infection control measures.

Key Highlights

• Bacterial pathogen epidemiology and clinical management
• Antibiotic stewardship and AMR mitigation
• Prevention strategies in healthcare and community settings
• Patient education and public health interventions
• Evidence-based treatment protocols

Why This Session Is Important?

Managing streptococcal and staphylococcal infections is vital for reducing disease burden. This session provides strategies to optimize treatment, prevent transmission, and protect population health.

Malaria and other protozoan diseases remain major contributors to global Infectious Diseases, requiring integration of Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization strategies. This session explores pathogen biology, vector ecology, and innovative interventions for disease control. Participants will learn about diagnostic advances, novel treatment approaches, and community-based prevention programs.

Antimicrobial Resistance (AMR) in protozoan infections poses additional challenges, necessitating evidence-informed strategies for treatment and monitoring. Attendees will gain insights into effective vector control, public health campaigns, and global initiatives that mitigate disease spread and improve population health outcomes.

Key Highlights

• Protozoan disease epidemiology and clinical care
• Vector control and preventive measures
• Vaccination and immunization strategies
• Antimicrobial resistance in protozoan infections
• Public health interventions and community engagement

Why This Session Is Important?

Effective malaria and protozoan disease management reduces mortality and improves health equity. This session equips professionals with tools for prevention, treatment, and community-based interventions.

Fungal infections in immunocompromised patients highlight challenges in Infectious Diseases, emphasizing Epidemiology & Public Health, Disease Prevention & Control, and vaccination where relevant. Participants will examine risk factors, infection dynamics, and evidence-based interventions to reduce morbidity and mortality. Clinical strategies for early detection, diagnosis, and therapy selection will be discussed in detail.

The session also explores Antimicrobial Resistance (AMR) concerns with fungal pathogens, stressing the need for vigilant stewardship and monitoring. Attendees will gain practical knowledge on implementing preventive protocols, supporting patient outcomes, and integrating public health strategies in high-risk populations.

Key Highlights

• Fungal infection epidemiology and high-risk populations
• Early detection and diagnostic strategies
• Antifungal therapy and resistance considerations
• Infection prevention in immunocompromised patients
• Integration of public health measures and clinical care

Why This Session Is Important?

Fungal infections can be life-threatening for vulnerable patients. This session equips clinicians with tools to diagnose, treat, and prevent infections effectively.

Emerging and evolving viral infections are a central focus of Infectious Diseases, requiring expertise in Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization strategies. This session covers the latest scientific developments, including antiviral drug innovations, vaccine platforms, and diagnostic advancements. Participants will explore how viral mutations influence disease spread, patient outcomes, and public health policies.

The session also addresses Antimicrobial Resistance (AMR) in secondary bacterial infections associated with viral diseases, highlighting integrated care approaches. Attendees will gain insights into coordinated public health interventions, outbreak preparedness, and evidence-based management strategies to enhance population health and mitigate viral threats.

Key Highlights

• Emerging viral pathogens and epidemiology
• Vaccine development and immunization programs
• Antiviral therapy and patient management
• Secondary infection and AMR mitigation
• Public health preparedness and disease prevention

Why This Session Is Important?

Understanding viral infections is critical for timely intervention and prevention. This session equips healthcare providers with strategies to respond effectively to emerging viral threats.

Understanding the mechanisms of bacterial pathogenesis is vital in Infectious Diseases, integrating Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. Participants will explore bacterial virulence factors, host immune responses, and molecular pathways that contribute to disease. Insights into pathogen evolution, transmission dynamics, and environmental influences help guide prevention and control strategies.

The session also emphasizes Antimicrobial Resistance (AMR) and its impact on clinical outcomes, highlighting stewardship programs and innovative therapeutic approaches. Attendees will gain practical strategies for applying molecular insights to improve patient care and reduce the spread of bacterial infections at a population level.

Key Highlights

• Molecular basis of bacterial virulence
• Host-pathogen interactions
• Antibiotic resistance and stewardship
• Vaccine and preventive strategies
• Public health implications and outbreak mitigation

Why This Session Is Important?

Deciphering bacterial pathogenesis enables precise interventions and effective infection control. This session equips professionals with knowledge to manage bacterial threats effectively.

Linking Infectious Diseases to Epidemiology & Public Health, this session examines strategies for disease monitoring, outbreak management, and vaccination initiatives. Participants will learn how population data informs intervention strategies and guides evidence-based policies. Emphasis is placed on integrating Disease Prevention & Control into healthcare systems and community outreach programs to reduce disease incidence and improve health equity.

The session also covers Antimicrobial Resistance (AMR) and its implications for public health, highlighting best practices for monitoring and mitigation. Attendees will explore case studies of successful vaccination programs, preventive campaigns, and multi-level public health interventions designed to curb the spread of infectious diseases.

Key Highlights

• Population health surveillance and epidemiology
• Vaccination campaigns and immunization strategies
• AMR monitoring and mitigation
• Preventive care and public health policy implementation
• Health promotion and community engagement

Why This Session Is Important?

Public health integration is crucial for controlling infectious threats. This session empowers professionals to design and implement strategies that safeguard communities.

Global health perspectives in Infectious Diseases emphasize Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. Participants will explore global surveillance systems, emerging infection hotspots, and strategies for coordinating responses across countries. Case studies will highlight the impact of socioeconomic factors and travel on disease spread.

This session also examines Antimicrobial Resistance (AMR) on a global scale, addressing stewardship, policy frameworks, and collaborative interventions. Attendees will gain insights into implementing evidence-based practices that enhance international disease control and reduce global health disparities.

Key Highlights

• Global disease epidemiology and burden
• Cross-border infection prevention
• Vaccination strategies in diverse settings
• AMR surveillance and global mitigation
• International collaboration and policy integration

Why This Session Is Important?

A global outlook is essential to combat infectious diseases effectively. This session equips professionals with knowledge for coordinated international prevention and control strategies.

Managing Infectious Diseases in geriatric populations requires a focus on Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. Participants will explore age-related immune decline, comorbidities, and strategies for preventing infection in nursing homes and hospitals. Evidence-based interventions and vaccination protocols for older adults will be highlighted to reduce morbidity and mortality.

The session also addresses Antimicrobial Resistance (AMR) challenges specific to elderly patients, including polypharmacy and resistant infections. Attendees will learn approaches for integrating preventive measures, vaccination campaigns, and stewardship programs to ensure safe and effective care for aging populations.

Key Highlights

• Infection risks and epidemiology in elderly patients
• Vaccination and preventive care strategies
• AMR management and stewardship
• Evidence-based interventions in long-term care
• Public health and geriatric-focused programs

Why This Session Is Important?

Geriatric populations are highly vulnerable to infections. This session equips clinicians with strategies to improve prevention, treatment, and quality of life for older adults.

Molecular biology and genomics are transforming Infectious Diseases research, supporting Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization initiatives. Participants will explore pathogen genomics, high-throughput sequencing, and molecular diagnostic tools that improve detection, surveillance, and outbreak management.

The session also highlights Antimicrobial Resistance (AMR) research using genomic tools to identify resistance mechanisms and guide therapeutic strategies. Attendees will gain knowledge on integrating genomics into clinical and public health practice, enabling precision interventions and enhancing population health outcomes.

Key Highlights

• Pathogen genomic characterization and sequencing
• Molecular diagnostics for infectious disease surveillance
• Vaccine development and precision medicine
• AMR detection and mitigation strategies
• Public health integration of genomics

Why This Session Is Important?

Genomic insights revolutionize infectious disease management. This session equips professionals with advanced tools to improve diagnosis, prevention, and treatment.

Innovative diagnostics play a critical role in Infectious Diseases, strengthening Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization initiatives. Participants will explore cutting-edge diagnostic technologies, including molecular assays, rapid antigen tests, and AI-driven detection platforms that enable early identification of pathogens.

The session also addresses Antimicrobial Resistance (AMR) monitoring and how novel diagnostics can guide targeted therapy and stewardship. Attendees will gain practical insights on integrating diagnostic innovations into clinical and public health workflows, enhancing disease detection, outbreak response, and overall patient outcomes.

Key Highlights

• Rapid and molecular diagnostic technologies
• Point-of-care testing and disease surveillance
• AMR detection and targeted therapy
• Integration of diagnostics with public health strategies
• Evidence-based approaches to outbreak management

Why This Session Is Important?

Early and accurate diagnosis is critical for controlling infectious diseases. This session equips healthcare providers with knowledge to implement advanced diagnostic solutions.

Vaccine development is at the forefront of combating Infectious Diseases, integrating Vaccines and Immunization, Epidemiology & Public Health, and Disease Prevention & Control. Participants will explore advancements in mRNA, viral vector, and protein subunit vaccines, as well as approaches to optimize immunogenicity and safety. The session will highlight the role of vaccination in controlling outbreaks, reducing disease burden, and improving population-level immunity.

The session also addresses Antimicrobial Resistance (AMR) indirectly by reducing infection rates and limiting unnecessary antibiotic use. Attendees will gain insights into designing and implementing effective immunization programs, overcoming vaccine hesitancy, and integrating vaccination strategies into broader public health frameworks to ensure equitable access and sustained disease prevention.

Key Highlights

• Advanced vaccine technologies and platforms
• Immunogenicity, efficacy, and safety evaluation
• Vaccination strategies in outbreak management
• AMR mitigation through vaccination
• Public health policy and immunization programs

Why This Session Is Important?

Vaccination is a cornerstone of infectious disease control. This session equips professionals with knowledge to implement effective vaccine strategies and enhance global health outcomes.

Artificial intelligence and big data are transforming the management of Infectious Diseases, supporting Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization strategies. Participants will learn how AI-driven tools can analyze complex datasets, predict outbreaks, and guide targeted interventions. Digital health solutions enhance decision-making, optimize resource allocation, and improve response times during emerging infectious threats.

The session also explores how these technologies support monitoring Antimicrobial Resistance (AMR) trends and evaluating vaccine coverage. Attendees will gain practical knowledge on integrating AI and big data analytics into clinical and public health workflows, enabling proactive, evidence-based strategies to mitigate infectious disease impact.

Key Highlights

• AI and big data applications in infectious disease surveillance
• Predictive modeling for outbreak management
• Digital tools for disease prevention and control
• AMR trend analysis and intervention planning
• Integration with vaccination and public health strategies

Why This Session Is Important?

Leveraging AI and big data enhances detection, prevention, and control of infectious diseases. This session equips professionals to apply innovative tools for improved population health outcomes.

The intersection of microbiology and immunology is critical for understanding Infectious Diseases, enhancing Vaccines and Immunization, Epidemiology & Public Health, and Disease Prevention & Control. Participants will explore the cellular and molecular mechanisms of immune responses, microbial pathogenesis, and emerging strategies to enhance protective immunity. The session will highlight innovations in immunotherapeutics, monoclonal antibodies, and prophylactic interventions.

Emphasis will also be placed on Antimicrobial Resistance (AMR) mechanisms and how immunological insights can guide alternative treatments and vaccine design. Attendees will gain knowledge to translate microbiology and immunology research into effective public health and clinical interventions, improving patient outcomes and disease control at the community level.

Key Highlights

• Host-pathogen interactions and immune responses
• Microbial characterization and diagnostics
• Vaccine development and immunotherapy
• AMR mechanisms and intervention strategies
• Public health integration of microbiology insights

Why This Session Is Important?

Understanding microbial and immune mechanisms is essential for infection prevention and therapy. This session equips professionals to apply scientific advances to enhance infectious disease control.

Socioeconomic factors play a major role in Infectious Diseases, shaping Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization strategies. Participants will examine how income, education, and access to healthcare influence disease transmission, vaccination coverage, and treatment outcomes. Insights from social determinants allow the design of targeted interventions that improve equity and reduce infection disparities.

The session also highlights Antimicrobial Resistance (AMR) trends linked to healthcare access and inappropriate antibiotic use. Attendees will explore evidence-informed strategies to address social barriers, enhance preventive programs, and optimize public health initiatives, ensuring comprehensive control of infectious diseases across diverse populations.

Key Highlights

• Influence of socioeconomic determinants on disease risk
• Health equity and access to vaccines
• AMR trends and social risk factors
• Community-targeted preventive and control strategies
• Policy development to mitigate infection burden

Why This Session Is Important?

Addressing social determinants is key to reducing infectious disease inequities. This session equips professionals with strategies to implement effective, equitable interventions.

Ethical considerations are critical in Infectious Diseases research, influencing Vaccines and Immunization, Epidemiology & Public Health, and Disease Prevention & Control. Participants will explore ethical frameworks for conducting clinical trials, ensuring informed consent, and maintaining transparency while testing novel therapies or vaccines. The session also examines dilemmas in resource allocation, outbreak response, and balancing individual rights with public safety.

The discussion includes Antimicrobial Resistance (AMR) research ethics, such as responsible reporting and stewardship during trials. Attendees will gain strategies to integrate ethical principles into research and public health programs, promoting trust, compliance, and equitable access to interventions.

Key Highlights

• Ethical frameworks for infectious disease research
• Vaccine and therapeutic trial design considerations
• Data privacy, informed consent, and public trust
• AMR research and responsible reporting
• Policy and public health ethics

Why This Session Is Important?

Ethical research ensures safe, responsible, and equitable interventions. This session equips professionals to navigate challenges while advancing infectious disease science.

Clinical case reports provide practical insights into Infectious Diseases, supporting Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization strategies. Participants will review rare or complex cases, analyze diagnostic methods, and explore therapeutic interventions. This session emphasizes learning from individual patient experiences to inform broader clinical and public health practices.

Additionally, the session highlights cases of Antimicrobial Resistance (AMR) and the role of early intervention in improving outcomes. Attendees will gain skills in documenting and interpreting cases, sharing lessons for improving disease control, patient management, and preventive strategies across diverse healthcare settings.

Key Highlights

• Rare and complex infectious disease cases
• Diagnostic and therapeutic innovations
• AMR-related case management
• Lessons for public health and clinical practice
• Evidence-based reporting

Why This Session Is Important?

Clinical case reports translate individual experiences into actionable knowledge. This session equips healthcare professionals to apply insights for better patient care and disease prevention.

Climate change significantly influences Infectious Diseases, connecting Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. Participants will explore the effects of rising temperatures, changing rainfall patterns, and extreme weather events on disease transmission and vector ecology. The session examines proactive strategies to anticipate outbreaks and protect vulnerable populations.

Emphasis is also placed on Antimicrobial Resistance (AMR) arising from environmental factors, including water and soil contamination. Attendees will learn evidence-based approaches to adapt public health measures, strengthen vaccination campaigns, and implement preventive strategies that mitigate climate-related infectious disease risks.

Key Highlights

• Climate impacts on infectious disease spread
• Vector-borne and environmental infection management
• Vaccination and preventive strategies in changing climates
• AMR implications of environmental changes
• Global policy and public health adaptation

Why This Session Is Important?

Climate-driven infectious disease challenges require proactive strategies. This session equips professionals to anticipate risks and implement effective preventive measures.

Addressing psychosocial factors enhances management of Infectious Diseases, integrating Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. Participants will explore psychological, social, and behavioral impacts of infectious disease outbreaks on patients, families, and communities. Interventions targeting adherence, vaccination acceptance, and behavioral change will be highlighted.

The session also covers the influence of Antimicrobial Resistance (AMR) awareness on patient behaviors and public compliance. Attendees will gain strategies to incorporate psychosocial care into clinical and public health practice, improving treatment outcomes and community engagement for better infectious disease control.

Key Highlights

• Mental health and behavioral support in infectious disease care
• Community education and engagement strategies
• Adherence to vaccination and preventive measures
• AMR awareness and behavioral interventions
• Integration of psychosocial support in public health

Why This Session Is Important?

Psychosocial considerations improve adherence, trust, and outcomes. This session equips professionals to address behavioral and mental health factors in disease management.